Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)

32:02
 
Share
 

Manage episode 478841195 series 2513286
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics:

  • Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00)
  • Comparing safety profiles of CDK4/6 inhibitors (9:49)
  • Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06)
  • Real-world evidence with CDK4/6 inhibitors (27:31)

CME information and select publications

  continue reading

1465 episodes

Artwork
iconShare
 
Manage episode 478841195 series 2513286
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics:

  • Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00)
  • Comparing safety profiles of CDK4/6 inhibitors (9:49)
  • Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06)
  • Real-world evidence with CDK4/6 inhibitors (27:31)

CME information and select publications

  continue reading

1465 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play